Enjoy complimentary customisation on priority with our Enterprise License!
The kidney transplantation therapeutics market share is expected to reach an estimated value of USD 1.16 billion by 2026 at an accelerating CAGR of 4.32%.
This kidney transplantation therapeutics industry forecast report extensively covers kidney transplantation therapeutics market segmentation by product (selective cytokine inhibitors, immunosuppressive antimetabolites, and other drugs) and geography (North America, Europe, Asia, and Rest of World (ROW)).
The kidney transplantation therapeutics market report also offers information on several market vendors, including AbbVie Inc., Asahi Kasei Corp., Astellas Pharma Inc., B Braun Melsungen AG, Bristol Myers Squibb Co., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Hansa Biopharma AB, Lifeline Scientific Inc., Novartis AG, Pfizer Inc., Preservation Solution Inc., Sanofi SA, Strides Pharma Science Ltd., TFF Pharmaceuticals Inc., TolerogenixX GmbH, and Transonic Systems Inc. among others. The report also provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches.
Download the Free Report Sample to Unlock the Kidney Transplantation Therapeutics Market Size for the Forecast Period and Other Important Statistics
The rising prevalence of CKD and renal impairments is notably driving the kidney transplantation therapeutics market growth, although factors such as side effects of immunosuppressants may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the kidney transplantation therapeutics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Kidney Transplantation Therapeutics Market Driver
One of the key factors driving the global kidney transplantation therapeutics industry growth is the rising prevalence of CKD and renal impairments owing to the increasing cases of diabetes, hypertension, vascular disease, and glomerulonephritis. CKD affects 8.5%-9.5% of the adult population across the globe. For instance, in South Africa, infections from Streptococcus species, hepatitis B and C viruses, and human immunodeficiency virus (HIV) are highly prevalent. In addition, in 2021, more than 1 in 7, that is 15% of the US adult population or 37 million people, were having CKD. CKD is also associated with an increased risk of cardiovascular diseases, infections, diabetes, and cancer. Such factors are expected to increase the need for kidney transplantation, which will subsequently augment the demand for kidney transplantation therapeutics during the forecast period.
Key Kidney Transplantation Therapeutics Market Trend
Novel techniques for kidney transplantation is one of the key kidney transplantation therapeutics market trends that is expected to impact the industry positively in the forecast period. Out of all the organ transplantation procedures, the number of kidney transplantation methods is very high (such as stem cells and tissue engineering) due to the high prevalence of risk factors for kidney failure. For instance, bioengineering has resulted in the successful production of a renal assist device with human cells, which was successfully used in humans in an extracorporeal setting. Similarly, organ printing is an upcoming technology, which can be a potential substitute for the traditional biodegradable solid scaffold-based techniques used in tissue engineering. Furthermore, investment in R and D is expected to lead to the introduction of novel approaches for kidney transplantation, which would further support the market growth in the coming years.
Key Kidney Transplantation Therapeutics Market Challenge
One of the key challenges to the global kidney transplantation therapeutics industry growth is the side effects of immunosuppressants. For instance, CellCept causes constipation, nausea, headache, diarrhea, vomiting, stomach pain, and loss of appetite. The side effects significantly affect the patient's adherence to the treatment using these drugs as they often last for a long time. Immunosuppressants are also known to cause side effects such as hyperglycemia, which is a condition that results in an increased blood sugar level, and secondary diabetes. This is expected to act as a barrier to the growth of the global kidney transplantation therapeutics market during the forecast period.
This kidney transplantation therapeutics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global kidney transplantation therapeutics market as a part of the pharmaceutical market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the kidney transplantation therapeutics market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the kidney transplantation therapeutics market encompasses successful business strategies deployed by the key vendors. The kidney transplantation therapeutics market is fragmented and the vendors are deploying growth strategies such as investments in R&D to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The kidney transplantation therapeutics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the kidney transplantation therapeutics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
47% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for kidney transplantation therapeutics in North America. Market growth in this region will be faster than the growth of the market in Europe.
The significant rise in the cases of transplantation procedures in countries such as the US and the availability of advanced healthcare infrastructure, which ensures the continuous supply of therapeutics to patients undergoing kidney transplantation, will facilitate the kidney transplantation therapeutics market growth in North America over the forecast period. For instance, as of January 2019, the Centers for Disease Control and Prevention (CDC) reported that kidney transplantation is the most common type of organ transplantation in the US.
This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The COVID-19 pandemic in 2020 had a negative impact on various industries, including the temporary closure of the manufacturing units of kidney transplantation therapeutics owing to the stringent COVID-19-related restrictions, such as nationwide lockdowns and stay-at-home regulations. However, in 2021, the demand for these products rebounded, as manufacturing activities were reopened due to COVID-19 vaccination drives. These factors will drive the growth of the regional kidney transplantation therapeutics market during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The kidney transplantation therapeutics market share growth by the selective cytokines inhibitors segment will be significant during the forecast period. This segment offers various branded and generic drugs, such as cyclosporine, tacrolimus, and sirolimus. Among these, tacrolimus is the major drug that is more often used in patients undergoing kidney transplantation due to its better therapeutic efficacy compared with other available drugs. Furthermore, the availability of tacrolimus in multiple dosage forms provides the option to adjust the dose as per a patient's needs. Owing to these factors, this segment of the market is expected to grow in the coming years.
This report provides an accurate prediction of the contribution of all the segments to the growth of the kidney transplantation therapeutics market size and actionable market insights on post COVID-19 impact on each segment.
|
Kidney Transplantation Therapeutics Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.32% |
|
Market growth 2022-2026 |
$ 1.16 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
3.61 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 47% |
|
Key consumer countries |
US, Canada, UK, Germany, Japan, and China |
|
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
|
Key companies profiled |
AbbVie Inc., Asahi Kasei Corp., Astellas Pharma Inc., B Braun Melsungen AG, Bristol Myers Squibb Co., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Hansa Biopharma AB, Lifeline Scientific Inc., Novartis AG, Pfizer Inc., Preservation Solution Inc., Sanofi SA, Strides Pharma Science Ltd., TFF Pharmaceuticals Inc., TolerogenixX GmbH, and Transonic Systems Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Get the report (PDF) sent to your email within minutes.
